Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Partners with Sage Science to Co-market DNA Size Selection Device

NEW YORK (GenomeWeb News) − Pacific Biosciences has partnered with Sage Science to co-market Sage's BluePippin DNA size selection device for use with the PacBio RS II single-molecule sequencer, the companies said today.

The BluePippin platform enables users to isolate DNA fragments of a specific length, ranging from 50 bases to 50 kilobases, in an automated way that can then be used to generate next-generation sequencing libraries.

Selecting long DNA fragments for library preparation increases the average read length generated on the PacBio RS II.

"We have found that the BluePippin size selection platform is very useful for applications where long read lengths are important, such as de novo genome assembly," said Kevin Corcoran, senior vice president of market development at Pacific Biosciences, in a statement.

Using the BluePippin "is an easy addition to our customers' sample prep workflow to select for 10 [kilobase] or larger fragments for sequencing on the PacBio RS II," he added.

Financial or other terms of the co-marketing agreement were not disclosed.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.